ES2182064T3 - Derivados de isoxazolidina. - Google Patents
Derivados de isoxazolidina.Info
- Publication number
- ES2182064T3 ES2182064T3 ES97919344T ES97919344T ES2182064T3 ES 2182064 T3 ES2182064 T3 ES 2182064T3 ES 97919344 T ES97919344 T ES 97919344T ES 97919344 T ES97919344 T ES 97919344T ES 2182064 T3 ES2182064 T3 ES 2182064T3
- Authority
- ES
- Spain
- Prior art keywords
- rent
- zero
- independently
- heterocicle
- optionally replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000002546 isoxazolidines Chemical class 0.000 title 1
- -1 MORPHOLINYL RING Chemical group 0.000 abstract 7
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 abstract 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical class [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 1
- 241000282693 Cercopithecidae Species 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical compound N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 abstract 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- AXLOCHLTNQDFFS-BESJYZOMSA-N azastene Chemical compound C([C@H]1[C@@H]2CC[C@@]([C@]2(CC[C@@H]1[C@@]1(C)C2)C)(O)C)C=C1C(C)(C)C1=C2C=NO1 AXLOCHLTNQDFFS-BESJYZOMSA-N 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Photoreceptors In Electrophotography (AREA)
- Developing Agents For Electrophotography (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
LA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA (I), LAS FORMAS N - OXIDO, LAS SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES Y SUS FORMAS ESTEREOQUIMICAMENTE ACEPTABLES, EN LOS QUE N ES DE CERO A 6; P ES DE CERO A 3; Q ES DE CERO A 3; R ES DE CERO A 3; R1 Y R2 SON INDEPENDIENTEMENTE CADA UNO HIDROGENO; ALQUILO C1-6 OPTATIVAMENTE SUSTITUIDO; ALQUILCARBONILO - C1-6 ; TRIHALOMETILCARBONILO; O R1 Y R2 , TOMADOS CONJUNTAMENTE CON EL ATOMO DE NITROGENO AL QUE VAN FIJADOS PUEDEN FORMAR UN ANILLO DE MORFOLINILO O UN HETEROCICLO OPTATIVAMENTE SUSTITUIDO. TANTO R3 COMO R4 SON INDEPENDIENTEMENTE HALO, CIANO, HIDROXI, TRIHALOMETILO, TRIHALOMETOXI, CARBOXILO, NITRO, AMINO, MONO - O DI (ALQUILO C1-6 )AMINO, ALQUILO - C1-6 CARBONILAMINO, AMINOSULFONILO, MONO - O DI - (ALQUILO - C1-6 ) AMINOSULFONILO, ALQUILO - C1-6 , ALQUILOXI - C1-6 , ALQUILCARBONILO C1-6 O ALQUILOXICARBONILO - C1-6 ; CADA R5 ES INDEPENDIENTEMENTE ALQUILO - C1-6 , CIANO O TRIHALOMETILO; X ES CR6 R7 , NR8 , O, S, S ( - O) O S (- O)2 ;CADA FORMULA (I) REPRESENTA INDEPENDIENTEMENTE UN HETEROCICLO AROMATICO BIVALENTE CARACTERIZADO PORQUE EL HETEROCICLO SE PUEDE SELECCIONAR DEL GRUPO FORMADO POR EL PIRROL, PIRRAZOL, IMIDAZOL, TRIAZOL, FURANO, TIOFENO, ISOXAZOL, OXAZOL, ISOTIAZOL, TIAZOL, PIRIDINA, PIRIDAZINA, PIRIMIDINA, PIRAZINA Y TRIAZINA; O UNO DE LOS DOS HETEROCICLOS AROMATICOS BIVALENTES DE LOS COMPUESTOS DE FORMULA (I) PODRIA SER EL 1,2 - BENCENDIILO; Y EL ARILO ES FENILO OPTATIVAMENTE SUSTITUIDO; SE REFIERE ADEMAS A COMPOSICIONES QUE INCLUYEN ESTOS COMPUESTOS, ASI COMO A SU USO COMO AGENTES TERAPEUTICOS EN EL TRATAMIENTO O LA PREVENCION DE TRASTORNOS DEL SNC, LOS PROBLEMAS CARDIOVASCULARES O TRASTORNOS GASTROINTESTINALES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96200991 | 1996-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2182064T3 true ES2182064T3 (es) | 2003-03-01 |
Family
ID=8223869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97919344T Expired - Lifetime ES2182064T3 (es) | 1996-04-12 | 1997-04-09 | Derivados de isoxazolidina. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6156747A (es) |
| EP (1) | EP0892804B1 (es) |
| JP (1) | JP4299884B2 (es) |
| KR (1) | KR100598724B1 (es) |
| CN (1) | CN1082963C (es) |
| AT (1) | ATE222911T1 (es) |
| AU (1) | AU716470B2 (es) |
| DE (1) | DE69714980T2 (es) |
| DK (1) | DK0892804T3 (es) |
| ES (1) | ES2182064T3 (es) |
| HU (1) | HU221608B (es) |
| IL (1) | IL123656A (es) |
| MY (1) | MY117456A (es) |
| NO (1) | NO310077B1 (es) |
| NZ (1) | NZ329954A (es) |
| PL (1) | PL186541B1 (es) |
| PT (1) | PT892804E (es) |
| TW (1) | TW514637B (es) |
| WO (1) | WO1997039001A1 (es) |
| ZA (1) | ZA973122B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO588297A0 (en) * | 1997-03-26 | 1997-04-24 | Luminis Pty Limited | Mediation in melatonin production |
| US20050148018A1 (en) | 1999-10-07 | 2005-07-07 | David Weiner | Methods of identifying inverse agonists of the serotonin 2A receptor |
| UA77650C2 (en) | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| SK11612003A3 (sk) * | 2001-02-21 | 2004-04-06 | Janssen Pharmaceutica N. V. | Izoxazolínové deriváty ako antidepresívne činidlá |
| AU2006209397B2 (en) * | 2005-01-27 | 2011-04-07 | Janssen Pharmaceutica N.V. | Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7414038A (nl) * | 1974-10-28 | 1976-05-03 | Akzo Nv | Nieuwe tetracyclische pyrrolidino derivaten. |
| CA2026925A1 (en) * | 1989-10-05 | 1991-04-06 | Hiroshi Fukumi | Tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use |
| US5552399A (en) * | 1994-11-02 | 1996-09-03 | Janssen Pharmaceutica N.V. | Substituted tetracyclic azepine derivatives |
| PL183618B1 (pl) * | 1994-11-02 | 2002-06-28 | Janssen Pharmaceutica Nv | Nowy związek, pochodna podstawionej tetracyklicznej oksazepiny lub tiazepiny, kompozycja farmaceutyczna i sposób wytwarzania pochodnej podstawionej tetracyklicznej oksazepiny lub tiazepiny |
-
1997
- 1997-04-09 HU HU9901875A patent/HU221608B/hu unknown
- 1997-04-09 AU AU23852/97A patent/AU716470B2/en not_active Expired
- 1997-04-09 PL PL97326871A patent/PL186541B1/pl unknown
- 1997-04-09 EP EP97919344A patent/EP0892804B1/en not_active Expired - Lifetime
- 1997-04-09 IL IL12365697A patent/IL123656A/en not_active IP Right Cessation
- 1997-04-09 NZ NZ329954A patent/NZ329954A/xx not_active IP Right Cessation
- 1997-04-09 KR KR1019980703537A patent/KR100598724B1/ko not_active IP Right Cessation
- 1997-04-09 ES ES97919344T patent/ES2182064T3/es not_active Expired - Lifetime
- 1997-04-09 PT PT97919344T patent/PT892804E/pt unknown
- 1997-04-09 DE DE69714980T patent/DE69714980T2/de not_active Expired - Lifetime
- 1997-04-09 JP JP53673497A patent/JP4299884B2/ja not_active Expired - Lifetime
- 1997-04-09 CN CN97191421A patent/CN1082963C/zh not_active Expired - Lifetime
- 1997-04-09 US US09/155,839 patent/US6156747A/en not_active Expired - Lifetime
- 1997-04-09 AT AT97919344T patent/ATE222911T1/de active
- 1997-04-09 WO PCT/EP1997/001830 patent/WO1997039001A1/en not_active Application Discontinuation
- 1997-04-09 DK DK97919344T patent/DK0892804T3/da active
- 1997-04-10 TW TW086104562A patent/TW514637B/zh not_active IP Right Cessation
- 1997-04-11 MY MYPI97001599A patent/MY117456A/en unknown
- 1997-04-11 ZA ZA973122A patent/ZA973122B/xx unknown
-
1998
- 1998-03-11 NO NO981077A patent/NO310077B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0892804T3 (da) | 2002-12-02 |
| WO1997039001A1 (en) | 1997-10-23 |
| AU716470B2 (en) | 2000-02-24 |
| JP2000508328A (ja) | 2000-07-04 |
| CN1205010A (zh) | 1999-01-13 |
| NZ329954A (en) | 1999-07-29 |
| HUP9901875A2 (hu) | 1999-09-28 |
| CN1082963C (zh) | 2002-04-17 |
| AU2385297A (en) | 1997-11-07 |
| HUP9901875A3 (en) | 2000-06-28 |
| HU221608B (hu) | 2002-11-28 |
| ZA973122B (en) | 1998-10-12 |
| PL186541B1 (pl) | 2004-01-30 |
| MY117456A (en) | 2004-06-30 |
| EP0892804A1 (en) | 1999-01-27 |
| KR100598724B1 (ko) | 2006-10-25 |
| US6156747A (en) | 2000-12-05 |
| IL123656A0 (en) | 1998-10-30 |
| JP4299884B2 (ja) | 2009-07-22 |
| TW514637B (en) | 2002-12-21 |
| PL326871A1 (en) | 1998-10-26 |
| NO310077B1 (no) | 2001-05-14 |
| KR19990067515A (ko) | 1999-08-25 |
| NO981077D0 (no) | 1998-03-11 |
| DE69714980T2 (de) | 2003-04-10 |
| IL123656A (en) | 2001-09-13 |
| ATE222911T1 (de) | 2002-09-15 |
| DE69714980D1 (de) | 2002-10-02 |
| PT892804E (pt) | 2003-01-31 |
| NO981077L (no) | 1998-10-12 |
| EP0892804B1 (en) | 2002-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032130A1 (es) | Un compuesto inhibidor de quinasas proteicas, una composicion farmaceutica que lo incluye, y un metodo para tratar afecciones con dicho compuesto | |
| PA8593101A1 (es) | Composiciones para el tratamiento de crecimiento celular anormal | |
| ES2188957T3 (es) | N-(4-(heteroarilmetil)fenil)-heteroarilaminas. | |
| PA8546601A1 (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6 | |
| AR041566A1 (es) | Derivados de indol utiles para el tratamiento de enfermedades | |
| PE108898A1 (es) | Derivados 6,5-heterobiciclicos sustituidos | |
| PE20040832A1 (es) | Derivados de indolil pirazinona | |
| UY27503A1 (es) | Nuevos derivados de piperazina | |
| ATE162521T1 (de) | 3-aminopiperidine derivate und verwandete stickstoff enthaltende heterocyclische verbindungen | |
| AR023727A1 (es) | Compuestos empleados en el tratamiento de padecimientos inflamatorios | |
| AR004219A1 (es) | Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios | |
| CO5700824A2 (es) | Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| AR028810A1 (es) | Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion | |
| CY1106679T1 (el) | Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα | |
| AR040870A1 (es) | Compuestos inhibidores de proteinquinasas y composicion farmaceutica que los comprende | |
| AR016762A1 (es) | Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo | |
| ATE390421T1 (de) | Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen | |
| PA8547901A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
| AR048567A1 (es) | Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas. | |
| CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
| EA200000400A1 (ru) | Галогензамещенные тетрациклические производные тетрагидрофурана | |
| NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| CL2003002565A1 (es) | Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci | |
| ES2107212T3 (es) | Derivados de 1,4-benzoxazina como abridores de los canales de potasio. | |
| AR035756A1 (es) | Uso de carbamatos en la preparacion de medicamentos para la prevencion o tratamiento de trastornos neurodegenerativos |